[go: up one dir, main page]

CA2119192A1 - Pharmaceutical Composition Having an Immunostimulant Activity - Google Patents

Pharmaceutical Composition Having an Immunostimulant Activity

Info

Publication number
CA2119192A1
CA2119192A1 CA2119192A CA2119192A CA2119192A1 CA 2119192 A1 CA2119192 A1 CA 2119192A1 CA 2119192 A CA2119192 A CA 2119192A CA 2119192 A CA2119192 A CA 2119192A CA 2119192 A1 CA2119192 A1 CA 2119192A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
immunostimulant activity
immunostimulant
activity
sulphur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2119192A
Other languages
French (fr)
Other versions
CA2119192C (en
Inventor
Georges Serge Grimberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2119192A1 publication Critical patent/CA2119192A1/en
Application granted granted Critical
Publication of CA2119192C publication Critical patent/CA2119192C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The new pharmaceutical composition is composed of four groups of products : a vitamin, sulphur, a complex biological cell and a cation.
CA002119192A 1993-03-18 1994-03-16 Pharmaceutical composition having an immunostimulant activity Expired - Fee Related CA2119192C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9303138 1993-03-18
FR9303138A FR2702655B1 (en) 1993-03-18 1993-03-18 NOVEL THERAPEUTIC COMPOSITION HAVING AN IMMUNOSTIMULATING EFFECT.

Publications (2)

Publication Number Publication Date
CA2119192A1 true CA2119192A1 (en) 1994-09-19
CA2119192C CA2119192C (en) 1998-07-14

Family

ID=9445112

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002119192A Expired - Fee Related CA2119192C (en) 1993-03-18 1994-03-16 Pharmaceutical composition having an immunostimulant activity

Country Status (5)

Country Link
EP (1) EP0615757A1 (en)
CA (1) CA2119192C (en)
FR (1) FR2702655B1 (en)
IL (1) IL108966A0 (en)
MA (1) MA23139A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5844799A (en) * 1999-04-08 2000-11-14 Airudin S. Khan Composition, containing sublimed sulphur, for altering plasma homodyst(e) levelsin humans
AU5844899A (en) * 1999-04-08 2000-11-14 Airudin S. Khan Composition, containing sublimed sulfur, for the treatment of lactose intolerance
WO2002062981A1 (en) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited A yeast human immunoregulator and the method for preparing it
WO2002062983A1 (en) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2002062985A1 (en) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2228470A1 (en) * 1973-05-09 1974-12-06 Degemont Marguerite Therapeutic compsn. contg. vitamin A, sulphur and live yeast - for treatment of disorders of the ear, nose and throat
FR2431863A1 (en) * 1978-07-24 1980-02-22 Martin Henri Vitamin=A, complex and sulphur dermatological compsn. - for treatment of seborrhoea eczema, acne, psoriasis etc., has sulphur as an organic cpd. or in mineral form
US4428933A (en) * 1982-08-02 1984-01-31 King John R Composition for treating acne, method of manufacturing said composition, and method of treating skin
FR2536996B1 (en) * 1982-12-01 1985-09-27 Grimberg Georges ASSOCIATION FOR IMPROVING THE ABSORPTION OF VARIOUS CATIONS BY THE ORGANIZATION
FR2647784B1 (en) * 1989-06-06 1991-10-04 Grimberg Georges COMBINATION OF VITAMIN A WITH PHYSIOLOGICAL DOSE AND DIFFERENT ACTIVE PRINCIPLES HAVING THERAPEUTIC ACTIVITY
FR2679775B1 (en) * 1991-08-01 1994-11-18 Grimbert Georges MEDICAMENT BASED ON NEUTRALIZED SULFUR DERIVATIVES.

Also Published As

Publication number Publication date
CA2119192C (en) 1998-07-14
IL108966A0 (en) 1994-06-24
FR2702655A1 (en) 1994-09-23
EP0615757A1 (en) 1994-09-21
MA23139A1 (en) 1994-10-01
FR2702655B1 (en) 1995-06-16

Similar Documents

Publication Publication Date Title
AU580843B2 (en) 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
AU8182387A (en) Galenical formulation
AU4607185A (en) Alpha-omega-dicarboxylic acids,process for their preparation and medicines composed thereof
AU585209B2 (en) Pleuromutilin derivatives, processes for their preparation and their uses
AU4585085A (en) Pharmaceutical oil-in-water type micro-emulsion
IL84041A (en) Retinoids,their manufacture and pharmaceutical compositions containing them
AU586034B2 (en) Benzothiazolones, and their production and use
AU5221890A (en) 4(3h)-pteridinones, preparation processes and drugs containing them
CA2097044A1 (en) Cyclopentane- and -pentene-.beta.-amino acids
IL88927A0 (en) Thienoazepines,their production and pharmaceutical compositions containing them
CA2119192A1 (en) Pharmaceutical Composition Having an Immunostimulant Activity
AU591892B2 (en) Peptides
AU628227B2 (en) Benzoxazinyl-pyrazoles, and their production and use
AU7143887A (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs
AU6292286A (en) N-substituted-3,4,5,6,-tetrahydrophthalimides, their preparation and use
AU7538187A (en) Pyrido (1,8) naphthyridinones and their use as pharmaceuticals
AU5360890A (en) Substituted azetidinylisothiazolopyridone derivatives, their preparation and their application as medicinal products
AU3945289A (en) 5-substituted-2,4-diphenylpyrimidine derivatives, their production and use
AU4442996A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
AU3904289A (en) Secondary polyetheramines, their production and use for the production of polyureas
AU628059B2 (en) 8,9-annelated beta-carbolines and 8,9-annelated-3,4-dihydro- beta-carbolines
AU587884B2 (en) Antibiotics, and their production
AU6438686A (en) 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
MY113432A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them
AU8082687A (en) 2,6-diamino-3-halobenzylpyridines and processes for their manufacture as well as their use in pharmaceuticals

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed